Max Healthcare Institute Limited
MAXHEALTH · Hospitals · NSE
₹1,029
Current Market Price
Fair Value (DCF)
₹466
Discount to FV
-54.7%
Updated 4h ago
YieldIQ Score
40/100
Piotroski F-Score
6/9
Economic Moat
Moderate
Confidence
41%
ROE
13.4%
Debt/Equity
0.32
WACC
9.5%
Market Cap
₹1.00 Lakh Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
16.6%
Return on capital employed
EV / EBITDA
43.0×
Enterprise multiple
Debt / EBITDA
1.5×
Leverage vs earnings
Interest Coverage
8.1×
EBIT covers interest
Current Ratio
0.89×
Short-term liquidity
Asset Turnover
0.49×
Revenue per ₹ of assets
Revenue CAGR (3Y)
23.1%
3-year revenue growth
Revenue CAGR (5Y)
22.9%
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹1,028.9
Bear case
Margin of Safety —
Implied upside -267.5%
Base case
Margin of Safety —
Implied upside -120.8%
Bull case
Margin of Safety -204.1%
Implied upside -67.1%
Ratio Trends
MAXHEALTH · last 6 annual periods
ROE
13.4%
ROCE
16.6%
Operating Margin
—
Debt / Equity
0.32×
PE
38.9×
EV / EBITDA
31.1×
Historical Financials
MAXHEALTH · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2022 NSE_XBRL | 2023 NSE_XBRL | 2024 NSE_XBRL | 2025 yfinance | 2026 yfinance | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹3883 Cr | ₹4489 Cr | ₹5309 Cr | ₹7028 Cr | ₹8373 Cr | +21.2% |
| EBITDA | ₹1050 Cr | ₹1367 Cr | ₹1655 Cr | ₹1931 Cr | ₹2357 Cr | +22.4% |
| EBIT | ₹840 Cr | ₹1148 Cr | ₹1425 Cr | — | — | +14.1% |
| PAT | ₹605 Cr | ₹1104 Cr | ₹1058 Cr | ₹1076 Cr | ₹1442 Cr | +24.3% |
| EPS (diluted) | ₹6.24 | ₹11.36 | ₹10.84 | — | — | +14.8% |
| CFO | ₹741 Cr | ₹1284 Cr | ₹1122 Cr | ₹1438 Cr | ₹1633 Cr | +21.9% |
| CapEx | ₹-553 Cr | ₹-336 Cr | ₹-786 Cr | ₹-944 Cr | ₹-1485 Cr | — |
| FCF | ₹187 Cr | ₹949 Cr | ₹336 Cr | ₹493 Cr | ₹149 Cr | -5.6% |
| Total Assets | ₹9189 Cr | ₹10.1K Cr | ₹12.0K Cr | ₹15.2K Cr | ₹17.2K Cr | +17.0% |
| Total Debt | ₹1139 Cr | ₹908 Cr | ₹1295 Cr | ₹3010 Cr | ₹3478 Cr | +32.2% |
| Shareholders' Equity | ₹6282 Cr | ₹7410 Cr | ₹8408 Cr | ₹9381 Cr | ₹10.7K Cr | +14.4% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
MAXHEALTH vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
 APOLLOHOSP Apollo Hospitals Enterprise Limited | -124.2%-55.4% upside | 40 | Above Fair Value | 20.5% | 54.9× |
 FORTIS Fortis Healthcare Limited | -132.6%-57.0% upside | 40 | Above Fair Value | 10.5% | 57.6× |
 NH Narayana Hrudayalaya Ltd. | -166.0%-62.4% upside | 35 | Above Fair Value | 17.8% | — |
 ASTERDM ASTERDM | — | — | Pending | 156.9% | — |
 MEDANTA Global Health Limited | -290.6%-74.4% upside | 40 | Data Limited | 14.1% | — |
Click a ticker to view its fair-value analysis.
Dividend History
3 ex-dividend events on file. Source: NSE corporate-actions feed.
Total paid (5Y)
₹4.00/sh
Last payout
2025-07-04
₹1.50
Peak payout
₹1.50
Trailing yield
0.15%
Amounts parsed from NSE subject lines. Percent-of-face-value declarations are converted using the per-ticker face value (defaults to ₹10).
AI Analysis Summary
Model-generated description of metrics. Not investment advice. Max Healthcare Institute Limited (MAXHEALTH.NS) trades at 1028.90 vs a model fair value of 466.00, a gap of -54.7%. Piotroski F-score: 6/...
Read full AI analysis →Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of MAXHEALTH →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for MAXHEALTH →
Compare
Head-to-head with peers
Compare MAXHEALTH side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse MAXHEALTHNow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.